Latest filing published 31 Aug 2018 for Creo Medical Group plc, €669k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -21.9%Entry £0.90 · Close at T+365 £0.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Craig Gulliford: trading record in brief
This profile gathers the share dealings of Craig Gulliford in Creo Medical Group plc. We count 3 filings; the first trade dates from 31 January 2017 and the latest from 30 August 2018.
Both buying and selling appear: 2 purchases worth €227k, against 1 sale worth €669k. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2018 to date brings 1 purchase and 1 sale.
On 31 August 2018 came the latest disclosure, an open-market sale for €669k in Creo Medical Group plc. The last insider purchase was made public on 20 August 2018, 3,002 days ago. The median gap between a trade and its publication by RNS (LSE) is 2 days. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Craig Gulliford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 480,000 shares@ £1.25100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180831113008_13774848_20200330111400472_427-0
- 480,000 sharesOff MarketISIN GB00BZ1BLL44FCA-NSM:LSE20180820101344_13761231_20200330111401385_9446-0Canonical exit: 15 Nov 2018 (T+90)
- 208,028 shares@ £0.93525.3% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20170202072156_13115252_20200330131513511_637Canonical exit: 1 May 2017 (T+90)
3 of 3 declarations